Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
, 1756 (2), 83-96

Mutant KRAS in Aberrant Crypt Foci (ACF): Initiation of Colorectal Cancer?

Affiliations
Review

Mutant KRAS in Aberrant Crypt Foci (ACF): Initiation of Colorectal Cancer?

Theresa P Pretlow et al. Biochim Biophys Acta.

Abstract

Since aberrant crypt foci (ACF) were first described in 1987, they have been the subjects of hundreds of papers; however, the debate continues about their role in colorectal tumorigenesis. This review focuses on the many phenotypic, genetic and epigenetic alterations in ACF that support the hypothesis that ACF are putative precursors of colorectal cancer in both humans and experimental animals. Human ACF, both with and without dysplasia, are monoclonal and display evidence of chromosomal instability. Both of these characteristics are shared by colorectal cancers. While most ACF do not have APC mutations, a large proportion has KRAS mutations and methylated SFRP1 and SFRP2 genes. This epigenetic inactivation gives rise to constitutive Wnt signaling in these putative precursors of colorectal cancer.

Similar articles

See all similar articles

Cited by 36 PubMed Central articles

See all "Cited by" articles

Publication types

LinkOut - more resources

Feedback